Piceatannol and mTOR inhibitor combination proves be an attractive therapeutic strategy for gastric cancer
This study is led by Dr. Longtao Huangfu, and Dr. Xiaoyang Wang (Peking University Cancer Hospital & Institute). A diet ...
This study is led by Dr. Longtao Huangfu, and Dr. Xiaoyang Wang (Peking University Cancer Hospital & Institute). A diet ...
In a study of patients with high-risk renal cell carcinoma, those who took the drug everolimus daily for up to ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net